PubMed:1545132
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 36-68 | protein | denotes | activation-inducer molecule/CD69 |
| T2 | 94-119 | protein | denotes | transcription factor AP-1 |
| T3 | 142-167 | protein | denotes | AP-1 transcription factor |
| T4 | 290-294 | protein | denotes | AP-1 |
| T5 | 307-343 | cell_type | denotes | human peripheral blood T lymphocytes |
| T6 | 401-405 | protein | denotes | CD69 |
| T7 | 464-472 | protein | denotes | AIM/CD69 |
| T8 | 544-551 | cell_type | denotes | T cells |
| T9 | 572-584 | protein | denotes | anti-AIM mAb |
| T10 | 632-644 | protein | denotes | anti-AIM mAb |
| T11 | 648-673 | cell_type | denotes | PMA-treated T lymphocytes |
| T12 | 716-720 | protein | denotes | AP-1 |
| T13 | 750-780 | DNA | denotes | phorbol ester response element |
| T14 | 795-807 | protein | denotes | anti-AIM mAb |
| T15 | 861-871 | protein | denotes | NF-kappa B |
| T16 | 875-895 | protein | denotes | transcription factor |
| T17 | 932-948 | protein | denotes | protein kinase C |
| T18 | 966-970 | protein | denotes | AP-1 |
| T19 | 1054-1059 | protein | denotes | c-fos |
| T20 | 1076-1081 | protein | denotes | c-jun |
| T21 | 1099-1120 | protein | denotes | DNA-binding complexes |
| T22 | 1129-1141 | protein | denotes | anti-Fos mAb |
| T23 | 1181-1186 | protein | denotes | c-Fos |
| T24 | 1194-1208 | protein | denotes | AP-1 complexes |
| T25 | 1220-1232 | protein | denotes | anti-AIM mAb |
| T26 | 1246-1250 | protein | denotes | AP-1 |
| T27 | 1289-1301 | protein | denotes | anti-AIM mAb |
| T28 | 1442-1446 | protein | denotes | AP-1 |
| T29 | 1516-1546 | cell_type | denotes | human peripheral blood T cells |
| T30 | 1607-1611 | protein | denotes | AP-1 |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 0-12 | NP | denotes | Human T cell |
| C1 | 0-23 | NP | denotes | Human T cell activation |
| C3 | 32-68 | NP | denotes | the activation-inducer molecule/CD69 |
| C5 | 94-119 | NP | denotes | transcription factor AP-1 |
| C4 | 78-119 | NP | denotes | the activity of transcription factor AP-1 |
| C6 | 138-167 | NP | denotes | the AP-1 transcription factor |
| C8 | 290-294 | NP | denotes | AP-1 |
| C7 | 290-303 | NP | denotes | AP-1 activity |
| C9 | 307-343 | NP | denotes | human peripheral blood T lymphocytes |
| C10 | 363-424 | NP | denotes | the activation inducer molecule (AIM)/CD69 activation pathway |
| C11 | 544-551 | NP | denotes | T cells |
| C12 | 572-584 | NP | denotes | anti-AIM mAb |
| C13 | 632-644 | NP | denotes | anti-AIM mAb |
| C15 | 716-720 | NP | denotes | AP-1 |
| C14 | 692-720 | NP | denotes | the binding activity of AP-1 |
| C16 | 724-727 | NP | denotes | its |
| C17 | 795-807 | NP | denotes | anti-AIM mAb |
| C18 | 861-871 | NP | denotes | NF-kappa B |
| C19 | 873-895 | NP | denotes | a transcription factor |
| C20 | 896-901 | NP | denotes | whose |
| C22 | 966-970 | NP | denotes | AP-1 |
| C21 | 966-987 | NP | denotes | AP-1-binding activity |
| C23 | 1054-1059 | NP | denotes | c-fos |
| C24 | 1068-1072 | NP | denotes | that |
| C25 | 1181-1186 | NP | denotes | c-Fos |
| C26 | 1190-1208 | NP | denotes | the AP-1 complexes |
| C27 | 1220-1232 | NP | denotes | anti-AIM mAb |
| C29 | 1246-1250 | NP | denotes | AP-1 |
| C28 | 1242-1259 | NP | denotes | the AP-1 activity |
| C30 | 1285-1301 | NP | denotes | the anti-AIM mAb |
| C32 | 1442-1446 | NP | denotes | AP-1 |
| C31 | 1442-1463 | NP | denotes | AP-1-binding activity |
| C34 | 1516-1546 | NP | denotes | human peripheral blood T cells |
| C33 | 1502-1546 | NP | denotes | activation of human peripheral blood T cells |
| C35 | 1555-1581 | NP | denotes | the AIM activation pathway |
| C37 | 1607-1611 | NP | denotes | AP-1 |
| C36 | 1591-1611 | NP | denotes | the activity of AP-1 |
| C38 | 1624-1636 | NP | denotes | this pathway |
| C40 | 1690-1696 | NP | denotes | T cell |
| C39 | 1684-1707 | NP | denotes | early T cell activation |
| R1 | C6 | C5 | coref-ident | the AP-1 transcription factor,transcription factor AP-1 |
| R2 | C8 | C6 | coref-ident | AP-1,the AP-1 transcription factor |
| R3 | C7 | C4 | coref-ident | AP-1 activity,the activity of transcription factor AP-1 |
| R4 | C9 | C2 | coref-ident | human peripheral blood T lymphocytes,Human T cell |
| R5 | C10 | C3 | coref-other | the activation inducer molecule (AIM)/CD69 activation pathway,the activation-inducer molecule/CD69 |
| R6 | C11 | C9 | coref-ident | T cells,human peripheral blood T lymphocytes |
| R7 | C13 | C12 | coref-ident | anti-AIM mAb,anti-AIM mAb |
| R8 | C15 | C8 | coref-ident | AP-1,AP-1 |
| R9 | C14 | C7 | coref-ident | the binding activity of AP-1,AP-1 activity |
| R10 | C16 | C15 | coref-pron | its,AP-1 |
| R11 | C17 | C13 | coref-ident | anti-AIM mAb,anti-AIM mAb |
| R12 | C19 | C18 | coref-appos | a transcription factor,NF-kappa B |
| R13 | C20 | C19 | coref-relat | whose,a transcription factor |
| R14 | C22 | C15 | coref-ident | AP-1,AP-1 |
| R15 | C21 | C14 | coref-ident | AP-1-binding activity,the binding activity of AP-1 |
| R16 | C24 | C21 | coref-pron | that,AP-1-binding activity |
| R17 | C25 | C23 | coref-ident | c-Fos,c-fos |
| R18 | C26 | C22 | coref-ident | the AP-1 complexes,AP-1 |
| R19 | C27 | C17 | coref-ident | anti-AIM mAb,anti-AIM mAb |
| R20 | C29 | C26 | coref-ident | AP-1,the AP-1 complexes |
| R21 | C28 | C21 | coref-ident | the AP-1 activity,AP-1-binding activity |
| R22 | C30 | C27 | coref-ident | the anti-AIM mAb,anti-AIM mAb |
| R23 | C32 | C29 | coref-ident | AP-1,AP-1 |
| R24 | C31 | C28 | coref-ident | AP-1-binding activity,the AP-1 activity |
| R25 | C34 | C11 | coref-ident | human peripheral blood T cells,T cells |
| R26 | C33 | C1 | coref-ident | activation of human peripheral blood T cells,Human T cell activation |
| R27 | C35 | C10 | coref-ident | the AIM activation pathway,the activation inducer molecule (AIM)/CD69 activation pathway |
| R28 | C37 | C32 | coref-ident | AP-1,AP-1 |
| R29 | C36 | C31 | coref-ident | the activity of AP-1,AP-1-binding activity |
| R30 | C38 | C35 | coref-ident | this pathway,the AIM activation pathway |
| R31 | C40 | C34 | coref-ident | T cell,human peripheral blood T cells |
| R32 | C39 | C33 | coref-other | early T cell activation,activation of human peripheral blood T cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-120 | Sentence | denotes | Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1. |
| S2 | 121-255 | Sentence | denotes | The induction of the AP-1 transcription factor has been ascribed to the early events leading to T cell differentiation and activation. |
| S3 | 256-425 | Sentence | denotes | We have studied the regulation of AP-1 activity in human peripheral blood T lymphocytes stimulated through the activation inducer molecule (AIM)/CD69 activation pathway. |
| S4 | 426-585 | Sentence | denotes | Phorbol esters are required to induce AIM/CD69 cell-surface expression as well as for triggering the proliferation of T cells in conjunction with anti-AIM mAb. |
| S5 | 586-781 | Sentence | denotes | Mobility shift assays showed that addition of anti-AIM mAb to PMA-treated T lymphocytes markedly enhanced the binding activity of AP-1 to its cognate sequence, the phorbol ester response element. |
| S6 | 782-949 | Sentence | denotes | In contrast, anti-AIM mAb did not induce any change in the binding activity of NF-kappa B, a transcription factor whose activity is also regulated by protein kinase C. |
| S7 | 950-1082 | Sentence | denotes | The increase in AP-1-binding activity was accompanied by the marked stimulation of the transcription of c-fos but not that of c-jun. |
| S8 | 1083-1233 | Sentence | denotes | Blockade of the DNA-binding complexes with an anti-Fos mAb demonstrated a direct participation of c-Fos in the AP-1 complexes induced by anti-AIM mAb. |
| S9 | 1234-1464 | Sentence | denotes | Most of the AP-1 activity could be eliminated when the anti-AIM mAb was added to the culture medium in the presence of cycloheximide, suggesting that de novo protein synthesis is crucial for the induction of AP-1-binding activity. |
| S10 | 1465-1612 | Sentence | denotes | These data provide the evidence that activation of human peripheral blood T cells through the AIM activation pathway regulate the activity of AP-1. |
| S11 | 1613-1715 | Sentence | denotes | Therefore, this pathway appears as a crucial step in the initiation of early T cell activation events. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-23 | other_name | denotes | Human T cell activation |
| T2 | 36-68 | protein_molecule | denotes | activation-inducer molecule/CD69 |
| T3 | 94-119 | protein_molecule | denotes | transcription factor AP-1 |
| T4 | 142-167 | protein_molecule | denotes | AP-1 transcription factor |
| T5 | 217-239 | other_name | denotes | T cell differentiation |
| T6 | 244-254 | other_name | denotes | activation |
| T7 | 290-294 | protein_molecule | denotes | AP-1 |
| T8 | 307-312 | multi_cell | denotes | human |
| T9 | 367-401 | other_name | denotes | activation inducer molecule (AIM)/ |
| T10 | 401-405 | protein_molecule | denotes | CD69 |
| T11 | 426-440 | other_organic_compound | denotes | Phorbol esters |
| T12 | 464-472 | protein_molecule | denotes | AIM/CD69 |
| T13 | 544-551 | cell_type | denotes | T cells |
| T14 | 572-584 | protein_molecule | denotes | anti-AIM mAb |
| T15 | 632-644 | protein_molecule | denotes | anti-AIM mAb |
| T16 | 648-651 | protein_molecule | denotes | PMA |
| T17 | 660-673 | cell_type | denotes | T lymphocytes |
| T18 | 716-720 | protein_molecule | denotes | AP-1 |
| T19 | 750-763 | other_organic_compound | denotes | phorbol ester |
| T20 | 795-807 | protein_molecule | denotes | anti-AIM mAb |
| T21 | 861-871 | protein_molecule | denotes | NF-kappa B |
| T22 | 875-895 | protein_family_or_group | denotes | transcription factor |
| T23 | 932-948 | protein_molecule | denotes | protein kinase C |
| T24 | 966-970 | protein_molecule | denotes | AP-1 |
| T25 | 1054-1059 | protein_molecule | denotes | c-fos |
| T26 | 1076-1081 | protein_molecule | denotes | c-jun |
| T27 | 1099-1120 | protein_complex | denotes | DNA-binding complexes |
| T28 | 1129-1141 | protein_molecule | denotes | anti-Fos mAb |
| T29 | 1181-1186 | protein_molecule | denotes | c-Fos |
| T30 | 1194-1198 | protein_molecule | denotes | AP-1 |
| T31 | 1220-1232 | protein_molecule | denotes | anti-AIM mAb |
| T32 | 1246-1250 | protein_molecule | denotes | AP-1 |
| T33 | 1289-1301 | protein_molecule | denotes | anti-AIM mAb |
| T34 | 1319-1333 | other_name | denotes | culture medium |
| T35 | 1353-1366 | other_organic_compound | denotes | cycloheximide |
| T36 | 1392-1409 | other_name | denotes | protein synthesis |
| T37 | 1442-1446 | protein_molecule | denotes | AP-1 |
| T38 | 1516-1521 | multi_cell | denotes | human |
| T39 | 1539-1546 | cell_type | denotes | T cells |
| T40 | 1559-1581 | other_name | denotes | AIM activation pathway |
| T41 | 1607-1611 | protein_molecule | denotes | AP-1 |
| T42 | 1684-1714 | other_name | denotes | early T cell activation events |